13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 39 holding rows worth $562,541,126.
- Accession
- 0001172661-25-002012
- Filer
- CIK 1792126
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 39 entries on the cover page, a total value of $562,541,126 stated on the cover page (in dollars after the unit check, H1), rows summing to $562,541,126 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 3,500,000 | $57,330,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,600,000 | $56,576,000 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 1,200,000 | $48,576,000 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 1,650,000 | $44,550,000 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 500,000 | $35,460,000 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,700,000 | $26,129,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 650,000 | $21,807,500 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 2,000,000 | $20,380,000 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 394,342 | $19,575,137 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 200,000 | $18,212,000 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 2,500,000 | $18,175,000 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 250,000 | $17,862,500 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 13,000,000 | $17,810,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 2,300,000 | $16,859,000 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 4,217,627 | $16,280,040 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 350,000 | $13,674,500 | dollars as filed | |
| GERON CORP | 374163103 | COM | 8,000,000 | $12,720,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,208,875 | $12,065,370 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 350,000 | $11,739,000 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 350,000 | $10,332,000 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 936,914 | $10,315,423 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 4,000,000 | $7,720,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 425,000 | $7,356,750 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 2,000,000 | $5,720,000 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 500,000 | $5,230,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 240,000 | $4,723,200 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 275,000 | $4,699,750 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,400,000 | $3,514,000 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,222,222 | $3,400,000 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 5,078,927 | $2,919,875 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 424,715 | $2,671,457 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 500,000 | $2,670,000 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 208,910 | $2,095,367 | dollars as filed | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 5,400,000 | $1,134,000 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 134,202 | $777,030 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 2,900,000 | $660,040 | dollars as filed | |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | COM | 145,089 | $435,267 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 100,000 | $370,000 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $15,920 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-25-002012 | this filing | 2025-05-15 | acceptance time not in the bulk data set |